Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia

NCT00129623 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT00129623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00129623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Placebo-controlled, Randomized, Multicenter Study to Assess the Efficacy and Safety of Oral Ibandronate Once Monthly in Postmenopausal Women With Osteopenia
Lead sponsor
Hoffmann-La Roche
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2007
Enrollment
160 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

post-menopausal osteopenia